Found: 7
Select item for more details and to access through your institution.
Efficacy and safety of crisaborole in patients with mild-tomoderate atopic dermatitis and other atopic comorbidities.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 425, doi. 10.2500/aap.2021.42.210064
- By:
- Publication type:
- Article
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 951, doi. 10.1007/s13555-023-00899-y
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1667, doi. 10.1007/s13555-021-00584-y
- By:
- Publication type:
- Article
Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 68, n. 2, p. 174, doi. 10.1111/j.1365-2125.2009.03444.x
- By:
- Publication type:
- Article
Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy.
- Published in:
- Bipolar Disorders, 2000, v. 2, n. 3, p. 248, doi. 10.1034/j.1399-5618.2000.20305.x
- By:
- Publication type:
- Article